UP
Upstream Bio, Inc. (UPB)
NASDAQ·Healthcare·Biotechnology
$2.80
+1.64%
Mkt Cap $153.36M
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (4 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+436.7%
Consensus $15.00 vs current $2.80
NASDAQ·Healthcare·Biotechnology
$2.80
+1.64%
Mkt Cap $153.36M
Buy
3
Hold
2
Sell
0
Price Target (4 analysts)
$15.00
Range $15.00 – $15.00
+436.7%
Consensus $15.00 vs current $2.80